END-OF-TREATMENT QUANTITATIVE HBSAG < 500 IU/ML CAN PREDICT SUSTAINED REMISSION AND HBSAG LOSS AFTER DISCONTINUATION OF NUCLEOS(T)IDE ANALOGUES IN CHRONIC HEPATITIS B Article Abdurakhmanov D., Panevkina S., Ibragimov E., Rozina T., Nikulkina E., Mazurchik N. HEPATOLOGY. WILEY-BLACKWELL. Vol. 72. 2020.
HBSAG LEVELS AS A GUIDE FOR FINITE TREATMENT DURATION OF CHRONIC HEPATITIS B Article Abdurakhmanov D., Ibragimov E., Rozina T., Nikulkina E., Mazurchik N. Clinics and Research in Hepatology and Gastroenterology. Elsevier Masson SAS. Vol. 43. 2019. P. e73-e75
THE SPECIFICITY AND SENSITIVITY OF THE CARBHYDRATE-DEFICIENT TRANSFERRIN IN THE DIAGNOSIS OF SEVERE ACUTE ALCOHOLIC HEPATITIS Article Ogurtsov P., Tarasova O., Mazurchik N. Conference Abstracts 26th Annual Conference of APASL.(China, Shanghai, Fefruary 15-19, 2017). No: PP0002 (S195-S196). [б.и.]. Vol. 11. 2017. P. 195-196
HBSAG QUANTITY FOR MONITORING OF HEPATITIS B VIRUS INFECTION IN INACTIVE CARRIERS Article Tarasova O., Garagulya E., Mazurchik N., Ogurtsov P. Hepatology International. Springer (India) Private Ltd.. Vol. Vol10. 2016. P. 213-213
LEVELS OF MICRO-RNA-122, MICRO-RNA-199A, MICRO-RNA-196, MICRO-RNA-491 AND MICRO-RNA-16 AND ANTIVIRAL THARAPY IN CHRONIC HCV-INFECTION Article Fedotova A., Tarasova O., Kritskaya L., Gimadiev R., Abramov A., Mazurchik N., Kochetov A., Ogurtsov P. AASLD/EASL Special Conference on Hepatitis C. New York, September 12-13, 2014. [б.и.]. 2014. P. 204-205
COMBINED THERAPY OF PREDNISOLONE AND PENTOXIFYLLINE IN SEVER ACUTE ALCOHOLIC HEPATITIS Article Tarasova O., Mazurchik N., Ogurtsov P. Hepatology International. Springer (India) Private Ltd.. Vol. Vol7. 2013. P. 39-40
EFFICACY OF ANTIVIRAL TREATMENT OF CHRONIC HEPATITIS C WITH PEG-IFN ALPHA-2B AND RIBAVIRIN IN COMBINATION WITH METFORMIN IN PATIENTS WITH HCV-1 GENOTYPE AND INSULIN RESISTANCE Article Khafisova O.O., Tarasova O., Mazurchik N., Ogurtsov P.P. HEPATOLOGY. WILEY-BLACKWELL. Vol. 58. 2013.